Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Immunology Letters|January 3, 2006
Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathwayJorge Nieva, Lisa Kerwin, Anita D Wentworth, et al.Hybridoma and Hybridomics|April 26, 2003
Rapid monoclonal antibody generation via dendritic cell targeting in vivoJody D Berry, Alexei Licea, Mikhail Popkov, et al.Bioorganic & Medicinal Chemistry Letters|November 12, 2017
PSMA-targeted bispecific Fab conjugates that engage T cellsJames T Patterson, Jason Isaacson, Lisa Kerwin, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2017
Chemically generated IgG2 bispecific antibodies through disulfide bridgingJames T Patterson, Edwige Gros, Heyue Zhou, et al.Frontiers in Oncology|June 6, 2022
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune CellsYoug R Thaker, Ianne Rivera, Christophe Pedros, et al.Antiviral Research|October 11, 2021
SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancementYing-Ting Wang, Robert D Allen, Kenneth Kim, et al.Cancer Research Communications|September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaAaron D Springer, Rengang Wang, Jiawei Wang, et al.Expert Opinion on Biological Therapy|December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMETReyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.Scientific Reports|September 15, 2022
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodiesXia Cao, Junki Maruyama, Heyue Zhou, et al.Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.Pageof 2